Argenx Se (ARGX) Tax Provisions (2017 - 2026)
Argenx Se (ARGX) posted Tax Provisions of -$60.0 million for Q1 2026, down 81.82% on a QoQ basis from -$33.0 million in Q1 2025, and down 81.82% year-over-year from -$330.0 million in Q1 2025.
Argenx Se (ARGX) Tax Provisions (2017 - 2026) Analysis & Trends
Argenx Se's Tax Provisions history runs 8 years deep, the most recent figure standing at -$60.0 million for Q1 2026.
- Quarterly Tax Provisions fell 81.82% year-over-year to -$60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$81.9 million (down 247.9% YoY) and the FY2025 annual result came in at -$13.4 million, up 98.2% from the prior year.
- Tax Provisions was -$60.0 million for Q1 2026 at Argenx Se, down from -$33.0 million in the prior quarter.
- Across five years, Tax Provisions topped out at $14.1 million in Q1 2022 and bottomed at -$60.0 million in Q1 2026.
- A 3-year average of -$20.5 million and a median of -$18.0 million in 2022 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2022 — Tax Provisions soared 225.8% — and 2026, when it tumbled 81.82%.
- Argenx Se's Tax Provisions stood at -$3.0 million in 2022, then slumped by 1016.75% to -$33.0 million in 2025, then plunged by 81.82% to -$60.0 million in 2026.
- Business Quant data shows ARGX's Tax Provisions at -$60.0 million in Q1 2026, -$33.0 million in Q1 2025, and -$3.0 million in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | 15.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -60.00 Mn |
| Mar 31, 2025 | -33.00 Mn |
| Jun 30, 2022 | -2.96 Mn |
| Mar 31, 2022 | 14.07 Mn |
| Jun 30, 2021 | -1.65 Mn |
| Mar 31, 2021 | -11.18 Mn |
| Dec 31, 2020 | 6.56 Mn |
| Mar 31, 2020 | -1.20 Mn |
| Dec 31, 2019 | 10.17 Mn |
| Mar 31, 2019 | -204,593.20 |
| Dec 31, 2018 | 869,744.08 |
| Sep 30, 2018 | 1,163.13 |
| Jun 30, 2018 | 36,996.78 |
| Dec 31, 2017 | 1.41 Mn |
| Jun 30, 2017 | -656,430.94 |